# Understanding societal challenges: a NeurotechEU perspective

**Authors:** Daniela Schulz, Carmen Lillo-Navarro, Marc Slors, Anett Hrabéczy, Martin Reuter

PMC · DOI: 10.3389/fnins.2024.1330470 · Frontiers in Neuroscience · 2024-07-26

## TL;DR

This paper explores public attitudes toward neuro-technologies in EU countries to guide ethical and user-focused development.

## Contribution

The study introduces a new questionnaire to assess societal perspectives on neuro-technological advances across multiple dimensions.

## Key findings

- Public acceptance of invasive neuro-technologies is low, with more worry than enthusiasm.
- The USCQ questionnaire evaluates six dimensions of societal perspectives on neuro-technologies.
- The study aims to identify demographic and personality variables linked to attitudes toward neuro-technologies.

## Abstract

Futuristic universities like The NeurotechEU and the technological innovations they provide will shape and serve society, but will also require support from society. Positive attitudes about neuro-technologies will increase their reach within society and may also impact policy-making, including funding decisions. However, the acceptability rates, especially of invasive neuro-technologies, are quite low and the majority of people are more worried than enthusiastic about them. The question therefore arises as to what neuro-technological advances should entail. In a rare effort to reach out to the public, we propose to conduct a trans-national survey with the goal to better understand the challenges of our NeurotechEU nations. We aim to compare and contrast our nations specifically with respect to their perspectives on neuro-technological advances, i.e., their needs for, interests in, access to, knowledge of and trust in neuro-technologies, and whether these should be regulated. To this end, we have developed the first version of a new tool—the Understanding Societal Challenges Questionnaire (USCQ)—which assesses all six of these dimensions (needs, interest, access, knowledge, trust, and policy-making) and is designed for administration across EU/AC countries. In addition to trans-national comparisons, we will also examine the links of our nations' perspectives on neuro-technological advances to demographic and personality variables, for example, education and socio-economic status, size of the residential area, the Big Five personality traits, religiosity, political standings, and more. We expect that this research will provide a deeper understanding of the challenges that our nations are facing as well as the similarities and differences between them, and will also help uncover the variables that predict positive and negative attitudes toward neuro-technological advances. By integrating this knowledge into the scientific process, The NeurotechEU may be able to develop neuro-technologies that people really care about, are ethical and regulated, and actually understood by the user.

## Full-text entities

- **Diseases:** falls (MESH:C537863), stroke (MESH:D020521), chronic pain (MESH:D059350), weight loss (MESH:D015431), pain (MESH:D010146), depression (MESH:D003866), hyperactivity-inattention (MESH:D001308), anxiety (MESH:D001007), neurological condition (MESH:D019636), COVID-19 (MESH:D000086382), -and conduct-related problems (MESH:D000076082), ES (MESH:D012512), spinal cord injuries (MESH:D013119), psychiatric (MESH:D001523), neurological diseases (MESH:D020271), DE (MESH:D003635), sensory-motor impairments (MESH:D015417), cognitive biases (MESH:D003072), obesity (MESH:D009765), Parkinson disease (MESH:D010300)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** CL-N — Homo sapiens (Human), Glioblastoma, Cancer cell line (CVCL_B1CV)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11313264/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11313264/full.md

## References

59 references — full list in the complete paper: https://tomesphere.com/paper/PMC11313264/full.md

---
Source: https://tomesphere.com/paper/PMC11313264